Pure Global

Effect of 2000-meter Rowing Test on Parameters of Intestinal Integrity in Elite Rowers During Competitive Phase - Trial NCT06372262

Access comprehensive clinical trial information for NCT06372262 through Pure Global AI's free database. This phase not specified trial is sponsored by Poznan University of Physical Education and is currently Completed. The study focuses on Endothelial Dysfunction. Target enrollment is 18 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06372262
Completed
other
Trial Details
ClinicalTrials.gov โ€ข NCT06372262
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of 2000-meter Rowing Test on Parameters of Intestinal Integrity in Elite Rowers During Competitive Phase

Study Focus

Endothelial Dysfunction

ergometer test

Observational

other

Sponsor & Location

Poznan University of Physical Education

Poznaล„, Poland

Timeline & Enrollment

N/A

Jun 01, 2022

Jun 30, 2022

18 participants

Primary Outcome

I-FABP (intestinal fatty acid binding protein)to measure epithelial wall injury,zonulin to measure tight junction leakage,LBP (lipopolysaccharide binding protein) to measure endotoxin,LPS (lipopolysaccharide) to measure endotoxin,Lactic acid to measure fatigue after the race

Summary

The study aimed to check the 2000m ergometer test on markers of gut permeability in the
 competitive phase of rowers. 18 members of the Polish rowing team took part in the study.

ICD-10 Classifications

Other peripheral vascular diseases
Atherosclerosis of arteries of extremities
Other specified peripheral vascular diseases
Renovascular hypertension
Other disorders of arteries and arterioles

Data Source

ClinicalTrials.gov

NCT06372262

Non-Device Trial